MedPath

Pyridoxine

Generic Name
Pyridoxine
Brand Names
Alertonic, Animi-3 With Vitamin D, Bonjesta, Citranatal B-calm Kit, Citranatal Harmony, Concept Ob, Diclectin, Diclegis, Folbic, Foltabs, Fortaplex, Infuvite, Infuvite Pediatric, Irospan 24/6 Kit, Isotamine B, Mvc-fluoride, Mvi Pediatric, Natafort, Neo-bex, Pregvit, Tandem Plus, Vitafol-one
Drug Type
Small Molecule
Chemical Formula
C8H11NO3
CAS Number
65-23-6
Unique Ingredient Identifier
KV2JZ1BI6Z
Background

Pyridoxine is the 4-methanol form of vitamin B6, an important water-soluble vitamin that is naturally present in many foods. As its classification as a vitamin implies, Vitamin B6 (and pyridoxine) are essential nutrients required for normal functioning of many biological systems within the body. While many plants and microorganisms are able to synthesize pyridoxine through endogenous biological processes, animals must obtain it through their diet.

More specifically, pyridoxine is converted to pyridoxal 5-phosphate in the body, which is an important coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. It's important to note that Vitamin B6 is the collective term for a group of three related compounds, pyridoxine, pyridoxal, and pyridoxamine, and their phosphorylated derivatives, pyridoxine 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate. Although all six of these compounds should technically be referred to as vitamin B6, the term vitamin B6 is commonly used interchangeably with just one of them, pyridoxine .

Vitamin B6, principally in its biologically active coenzyme form pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA) .

Pyridoxine is used medically for the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy (due to Isoniazid's mechanism of action which competitively inhibits the action of pyridoxine in the above-mentioned metabolic functions). It is also used in combination with Doxylamine (as the commercially available product Diclectin) for the treatment of nausea and vomiting in pregnancy.

Indication

Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of Isoniazid-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with Doxylamine (as the commercially available product Diclectin).

Associated Conditions
Back pain, Dizziness, Fever, Headache, Hepatic; Functional Disturbance, Hepatitis, Iron Deficiency Anemia (IDA), Ketosis, Macrocytic anemia, Menière's Disease, Menstrual Distress (Dysmenorrhea), Metabolic Acidosis, Motion Sickness, Myalgia, Nausea and vomiting, Neuralgia, Sciatic, Neuritis, Neurological Conditions caused by B Vitamin Deficiency, Secondary anemia, Toothache, Toxinfectious state, Trigeminal Neuralgia (TN), Vitamin B1 deficiency, Vitamin B12 Deficiency, Vitamin B6 Deficiency, Vitamin Deficiency, Minor aches and pains, Minor pain
Associated Therapies
Nutritional supplementation, Supplementation, Vitamin supplementation, Wellness of the Liver

Oral Misoprostol Before Endometrial Biopsy

Phase 3
Completed
Conditions
Endometrial Biopsy
Interventions
First Posted Date
2005-09-20
Last Posted Date
2007-09-21
Lead Sponsor
Memorial University of Newfoundland
Target Recruit Count
72
Registration Number
NCT00200226
Locations
🇨🇦

Women's Health Centre, Eastern Health, St. John's, Newfoundland and Labrador, Canada

🇨🇦

Obstetrics and Gynecology Associates, Dartmouth, Nova Scotia, Canada

Treatment of Acute Schizophrenia With Vitamin Therapy

Phase 4
Completed
Conditions
Acute Schizophrenia
First Posted Date
2005-09-01
Last Posted Date
2009-11-25
Lead Sponsor
Beersheva Mental Health Center
Target Recruit Count
55
Registration Number
NCT00140166
Locations
🇮🇱

Beersheva Mental Health Center, Beersheva, Israel

BVAIT: B-Vitamin Atherosclerosis Intervention Trial

Phase 2
Completed
Conditions
Atherosclerosis
First Posted Date
2005-06-15
Last Posted Date
2009-12-11
Lead Sponsor
National Institute on Aging (NIA)
Target Recruit Count
506
Registration Number
NCT00114400
Locations
🇺🇸

Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles, California, United States

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

Phase 2
Withdrawn
Conditions
Colorectal Cancer
Interventions
First Posted Date
2003-10-07
Last Posted Date
2012-06-07
Lead Sponsor
SWOG Cancer Research Network
Registration Number
NCT00070434

VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)

Phase 3
Completed
Conditions
Alzheimer's Disease
First Posted Date
2003-03-10
Last Posted Date
2009-06-12
Lead Sponsor
National Institute on Aging (NIA)
Target Recruit Count
340
Registration Number
NCT00056225
Locations
🇺🇸

Georgetown University, Washington, DC, District of Columbia, United States

🇺🇸

Mayo Clinic, Scottsdale, Scottsdale, Arizona, United States

🇺🇸

Southern Illinois University, Springfield, Illinois, United States

and more 35 locations

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Not Applicable
Completed
Conditions
HIV Infections
Tuberculosis
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
525
Registration Number
NCT00000796
Locations
🇺🇸

Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, Bronx, New York, United States

🇺🇸

Cook County Hosp, Chicago, Illinois, United States

🇺🇸

Bronx Lebanon Hosp Ctr, Bronx, New York, United States

and more 18 locations

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Not Applicable
Completed
Conditions
HIV Infections
Tuberculosis
First Posted Date
2001-08-31
Last Posted Date
2021-11-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
2000
Registration Number
NCT00000636
Locations
🇺🇸

AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

🇺🇸

Philadelphia FIGHT, Philadelphia, Pennsylvania, United States

🇺🇸

Boston Dept of Health and Hosps, Boston, Massachusetts, United States

and more 22 locations

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Not Applicable
Completed
Conditions
Tuberculosis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
2000
Registration Number
NCT00000638
Locations
🇺🇸

Moses H Cone Memorial Hosp, Greensboro, North Carolina, United States

🇺🇸

State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore, Maryland, United States

🇺🇸

Johns Hopkins Hosp, Baltimore, Maryland, United States

and more 73 locations

The Treatment of Tuberculosis in HIV-Infected Patients

Phase 3
Completed
Conditions
HIV Infections
Tuberculosis
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
650
Registration Number
NCT00001033
Locations
🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

🇺🇸

Univ. of Miami AIDS CRS, Miami, Florida, United States

🇺🇸

Cook County Hosp. CORE Ctr., Chicago, Illinois, United States

and more 9 locations

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Not Applicable
Completed
Conditions
Tuberculosis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
600
Registration Number
NCT00000959
Locations
🇺🇸

Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States

🇺🇸

Clinical Directors Network of Region II, New York, New York, United States

🇺🇸

Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath